Holdings (as at 2025-03-21)
Percentage of net assets may not equal 100%
Security Name % of Net Assets
First Trust NYSE® Arca® Biotechnology Index Fund 99.83%
Holdings of FBT - First Trust NYSE® Arca® Biotechnology Index Fund
(as at 2025-03-21)
Security Name % of Net Assets
BeiGene, Ltd. (ADR) 4.85%
Intra-Cellular Therapies, Inc. 4.72%
Halozyme Therapeutics, Inc. 4.20%
Alkermes Plc 4.19%
Vertex Pharmaceuticals Incorporated 4.18%
Amgen Inc. 4.10%
Alnylam Pharmaceuticals, Inc. 4.05%
Gilead Sciences, Inc. 4.05%
Corcept Therapeutics Inc. 4.00%
BioMarin Pharmaceutical Inc. 3.60%
Exelixis, Inc. 3.49%
Mettler-Toledo International Inc. 3.37%
ACADIA Pharmaceuticals Inc. 3.31%
Waters Corporation 3.27%
Biogen Inc. 3.22%
Regeneron Pharmaceuticals, Inc. 3.21%
argenx SE (ADR) 3.19%
Repligen Corporation 3.07%
Genmab A/S (ADR) 3.03%
Incyte Corporation 2.99%
Natera, Inc. 2.94%
United Therapeutics Corporation 2.92%
Exact Sciences Corporation 2.75%
Neurocrine Biosciences, Inc. 2.70%
BioNTech SE (ADR) 2.64%
Moderna, Inc. 2.63%
Veracyte, Inc. 2.61%
Bruker Corporation 2.49%
Illumina, Inc. 2.18%
Sarepta Therapeutics, Inc. 2.02%
Dreyfus Government Cash Management (Institutional Shares) 0.08%
US Dollar 0.00%

Holdings are subject to change.

Commissions, management fees and expenses all may be associated with Exchange-Traded Fund investments. Please carefully read the prospectus of the fund before investing. Exchange-Traded funds are not guaranteed, their values change frequently and past performance may not be repeated.